Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 27 Apr 2023
In the second week of life, 83 percent of newborns who were fed formula milk had Clostridium difficile and Clostridium perfringens, but by the end of the third week, all infants had these infections.
Read Full News8 Pulmonology Headlines You Missed in September 2026
The Accelerating Access to Critical Therapies for ALS Reauthorization Act of 2026 extends federal support for ALS research and expanded access to investigational therapies, with additional provisions addressing clinical trial oversight and regulatory planning.
The professor of neurology at the University of Lyon and 2026 Rachel Horne Prize Winner discussed pregnancy counseling, therapeutic inertia, and overlooked women's health issues in multiple sclerosis.
Jennifer Soung, MD, and Mona Shahriari, MD, discuss diagnosing psoriasis in diverse skin tones and why severity scores overlook dyspigmentation.
AMETHYST: Litifilimab Sustains CLE Gains at 52 Weeks, With Victoria Werth, MD
EADV Congress 2026: Day 3 Recap—5 Headlines to Know
Upadacitinib Tops Nemolizumab on Skin, Itch Targets in Indirect Analysis
1.
Rare Tumor in a Rare Location in Patient With Constipation
2.
Smoldering Myeloma: The Treatment Issue Is Getting Trickier
3.
Better treatments buoy multiple-myeloma patients, bound by research cuts and racial disparities
4.
Retifanlimab-Chemo Combo Boosts PFS in Advanced Squamous Cell Anal Cancer
5.
Survival is extended by a new treatment option for metastatic colorectal cancer.
1.
The Oncologist’s Edge: Tools, Trials, and Tech Transforming Treatment
2.
Navigating the Stages of Thyroid Cancer: A Guide for Patients
3.
Exploring the Normal Range of Monocytes: A Comprehensive Guide
4.
Transfusing the Future: Exploring the Possibilities of Blood Transfusions
5.
Essential Developments in Oncology for Healthcare Excellence
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
1.
Navigating the Brain Barrier: The CNS Challenge in ALK+ NSCLC
2.
INO-VATE: The Long-Term Overall Survival Analysis in Iontuzumab-Treated Patients
3.
How Nutrition Can Support Patients During Cancer Care
4.
First Line Combination Therapy- The Overall Survival Data in NSCLC Patients
5.
Managing Common Side Effects During Cancer Treatment
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge